Treatment of Primary Biliary Cirrhosis with Ursodeoxycholic Acid, Budesonide and Fibrates

Publisher： Karger

E-ISSN： 1421-9875|29|1|85-88

ISSN： 0257-2753

Source： Digestive Diseases, Vol.29, Iss.1, 2011-06, pp. : 85-88

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ursodeoxycholic acid and histological progression in primary biliary cirrhosis

By Chan C.-W.   V. Papatheodoridis G.   Goulis J.   K. Burroughs A.  

Journal of Hepatology, Vol. 39, Iss. 6, 2003-12 ,pp. : 1094-1095

Elsevier

Access to resources Recommend Favorite

Methotrexate in Patients with Primary Biliary Cirrhosis Who Respond Incompletely to Treatment With Ursodeoxycholic Acid

By Kaplan Marshall   Bonder Alan   Ruthazer Robin   Bonis Peter  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3207-3217

Springer Publishing Company

Access to resources Recommend Favorite

Pentoxifylline, but not ursodeoxycholic acid or tauroursodeoxycholic acid inhibits the proliferative effect of sera samples from primary biliary cirrhosis patients

By Peterson T.C.   Huet P.-M.  

International Hepatology Communications, Vol. 7, Iss. 2, 1997-06 ,pp. : 94-104

Elsevier

Access to resources Recommend Favorite

Therapy of Primary Biliary Cirrhosis: Novel Approaches for Patients with Suboptimal Response to Ursodeoxycholic Acid

By  

Digestive Diseases, Vol. 33, Iss. 2, 2015-0 ,pp. : 125-133

Karger

Access to resources Recommend Favorite

Phlebotomy in the treatment of primary biliary cirrhosis

By Akbal Erdem   Koçak Erdem   Taş Adnan   Köklü Seyfettin  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 1, 2010-01 ,pp. : 124-125

Informa Healthcare

Access to resources Recommend Favorite